nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review
|
Jelicic, Jelena |
|
|
22 |
11 |
p. e981-e991 |
artikel |
2 |
Cost-Effectiveness of PET Directed Versus Combined Modality Therapy for Early-Stage Favorable Hodgkin's Lymphoma
|
Smith, Clayton P. |
|
|
22 |
11 |
p. e992-e999 |
artikel |
3 |
CyBorD-DARA in Newly Diagnosed Transplant-Eligible Multiple Myeloma: Results from the 16-BCNI-001/CTRIAL-IE 16-02 Study Show High Rates of MRD Negativity at End of Treatment
|
Swan, D. |
|
|
22 |
11 |
p. 847-852 |
artikel |
4 |
Editorial Board
|
|
|
|
22 |
11 |
p. A1-A2 |
artikel |
5 |
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials
|
Dixon, Jesse G. |
|
|
22 |
11 |
p. e1009-e1018 |
artikel |
6 |
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments
|
Fernandez, Nicolas |
|
|
22 |
11 |
p. 853-862 |
artikel |
7 |
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations
|
Yasuda, Hajime |
|
|
22 |
11 |
p. 805-811 |
artikel |
8 |
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients
|
Ahmed, Gulrayz |
|
|
22 |
11 |
p. 863-868 |
artikel |
9 |
Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma
|
Major, Ajay |
|
|
22 |
11 |
p. e1000-e1008 |
artikel |
10 |
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements
|
Bliven, Sean Patrick |
|
|
22 |
11 |
p. 825-834 |
artikel |
11 |
Pediatric Plasma Cell Neoplasms: A Population-Based Study
|
Loap, Pierre |
|
|
22 |
11 |
p. 841-846 |
artikel |
12 |
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma
|
Yoon, Sang Eun |
|
|
22 |
11 |
p. e972-e980 |
artikel |
13 |
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke
|
Narezkina, Anna |
|
|
22 |
11 |
p. e959-e971 |
artikel |
14 |
Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant
|
Chiu, May |
|
|
22 |
11 |
p. 835-840 |
artikel |
15 |
SOHO State of the Art Updates and Next Questions | Asparaginase—Understanding and Overcoming Toxicities in Adults with ALL
|
Aldoss, Ibrahim |
|
|
22 |
11 |
p. 787-794 |
artikel |
16 |
SOHO State of the Art Updates and Next Questions | Mechanisms of Resistance to BCL2 Inhibitor Therapy in Chronic Lymphocytic Leukemia and Potential Future Therapeutic Directions
|
Bennett, Rory |
|
|
22 |
11 |
p. 795-804 |
artikel |
17 |
Table of Contents
|
|
|
|
22 |
11 |
p. A3-A5 |
artikel |
18 |
Treatment Landscape of Relapsed/Refractory Mantle Cell Lymphoma: An Updated Review
|
Al-Mansour, Mubarak |
|
|
22 |
11 |
p. e1019-e1031 |
artikel |
19 |
Up-front Therapy With CHOP Plus Etoposide in Brazilian nodal PTCL Patients: Increased Toxicity and No Survival Benefit Compared to CHOP Regimen–Results of a Real-Life Study From a Middle-Income Country
|
Lage, Luís Alberto de Pádua Covas |
|
|
22 |
11 |
p. 812-824 |
artikel |